UnitedHealth Group (NYSE:UNH) Given New $625.00 Price Target at Deutsche Bank Aktiengesellschaft

UnitedHealth Group (NYSE:UNH) had its price target upped by Deutsche Bank Aktiengesellschaft from $595.00 to $625.00 in a research report report published on Tuesday,Benzinga reports. They currently have a buy rating on the healthcare conglomerate’s stock.

Other analysts also recently issued reports about the stock. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Stephens cut their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Barclays upped their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a report on Wednesday, November 27th. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $625.26.

UnitedHealth Group Stock Down 5.2 %

Shares of UNH stock opened at $578.97 on Tuesday. The stock has a market cap of $532.81 billion, a P/E ratio of 37.72, a PEG ratio of 1.78 and a beta of 0.58. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $587.48 and its two-hundred day simple moving average is $558.34.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.56 EPS. Analysts predict that UnitedHealth Group will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Institutional Trading of UnitedHealth Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter worth $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. Macroview Investment Management LLC lifted its holdings in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new position in UnitedHealth Group during the third quarter valued at $32,000. Finally, Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group during the second quarter valued at $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.